Title:
The Actions to Control Cardiovascular Risks in Diabetes (Accord) Eye Study Results
Objectives:
Upon completion of this activity, participants will be able to: Provide better understanding of the results of the ACCORD Eye Study and its clinical applications. To evaluate the effects of fenofibrate on the lipid profile. To examine the possibility that the effect of fenofibrate on the progression of diabetic retinopathy mediated by its effect on the serum lipids
Speaker:
Emily Y. Chew, MD, Deputy Director, Division of Epidemiology and Clinical Applications National Eye Institute, Chief of Clinical Trials Branch, National Institutes of Health, Bethesda, Maryland
For more information contact:
Sharon Silliman
Department of Medicine
271-3935
sharon-silliman@ouhsc.edu